You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

refractory cytopenia

Showing 1 - 25 of 8,961
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Lymphoblastic Leukemia in Remission, Adult

Terminated
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • +9 more
  • Allogeneic Bone Marrow Transplantation
  • +7 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 4, 2021

Bone Marrow Failure Disorders, Aplastic Anemia, Thrombocytopenia Trial in Iowa City (Romiplostim)

Recruiting
  • Bone Marrow Failure Disorders
  • +4 more
  • Iowa City, Iowa
    University of Iowa Hospitals & Clinics
Jun 4, 2021

Clonal Cytopenia of Undetermined Significance, High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements, Recurrent

Recruiting
  • Clonal Cytopenia of Undetermined Significance
  • +6 more
  • Ascorbic Acid
  • +12 more
  • Scottsdale, Arizona
  • +4 more
May 26, 2022

AML, ALL, Undifferentiated Leukemia Trial in Boston (Abatacept)

Completed
Has Results
  • AML
  • +11 more
  • Boston, Massachusetts
    Boston Children's Hospital
Oct 31, 2019

Autoimmune Hemolytic Anemia, Pure Red Cell Aplasia, Evans Syndrome Trial in Beijing (Tacrolimus)

Unknown status
  • Autoimmune Hemolytic Anemia
  • +2 more
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Dec 1, 2019

Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndrome Trial in

Completed
Has Results
  • Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative
  • +13 more
  • Salt Lake City, Utah
  • +2 more
Jan 15, 2020

Immune Thrombocytopenia, Warm Autoimmune Hemolytic Anemia Trial in Créteil (Ninlaro)

Withdrawn
  • Immune Thrombocytopenia
  • Warm Autoimmune Hemolytic Anemia
  • Créteil, France
    Mahevas
Oct 25, 2019

Warm Autoimmune Hemolytic Anemia Trial in Beijing (Sirolimus)

Not yet recruiting
  • Warm Autoimmune Hemolytic Anemia
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Jun 21, 2023

Refractory Non-Hodgkin Lymphoma, Relapsed Non-Hodgkin Lymphoma Trial in Spain (ARI0003)

Not yet recruiting
  • Refractory Non-Hodgkin Lymphoma
  • Relapsed Non-Hodgkin Lymphoma
  • ARI0003
  • Santiago De Compostela, A Coruña, Spain
  • +6 more
Oct 24, 2023

Non-Hodgkin Lymphoma Trial in United States (GDA-201)

Recruiting
  • Non-Hodgkin Lymphoma
  • Maywood, Illinois
  • +4 more
Nov 30, 2022

MDS Trial in Beijing (Roxadustat, Luspatercept)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Beijing, China
    Peking union medical college hospital
Aug 17, 2023

Acute Myeloid Leukemia Trial in Hangzhou (RC1012 injection (allo-DNT cells))

Recruiting
  • Acute Myeloid Leukemia
  • RC1012 injection (allo-DNT cells)
  • Hangzhou, Zhejiang, China
    First Affiliated Hospital of Zhejiang University
Aug 3, 2022

Multiple Myeloma Trial in New York (drug, biological, procedure)

Active, not recruiting
  • Multiple Myeloma
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 3, 2023

Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid

Completed
  • Adult Acute Myeloid Leukemia in Remission
  • +16 more
  • iodine I 131 monoclonal antibody BC8
  • +7 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Nov 8, 2019

MDS Trial in Beijing (Lenalidomide, Azacitidine)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Beijing, China
    Peking union medical college hospital
Aug 16, 2023

Systemic Lupus Erythematosus Trial in Seoul (CS20AT04 (allogenic bone marrow derived mesenchymal stem cell))

Recruiting
  • Systemic Lupus Erythematosus
  • CS20AT04 (allogenic bone marrow derived mesenchymal stem cell)
  • Seoul, Korea, Republic of
    Hanyang University Medical Center
Apr 6, 2021

Immune Thrombocytopenia Trial (Daratumumab Injection)

Not yet recruiting
  • Immune Thrombocytopenia
  • Daratumumab Injection
  • (no location specified)
Sep 28, 2022

Evan Syndrome, Treatment Trial in Tianjin (Anti-CD38 antibody Injection)

Recruiting
  • Evan Syndrome
  • Treatment
  • Anti-CD38 antibody Injection
  • Tianjin, Tianjin, China
    Chinese Academy of Medical Science and Blood Disease Hospital
Aug 25, 2023

MDS Trial run by the National Cancer Institute (NCI) (decitabine and cedazuridine, BMS-986253)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 17, 2022

Chronic Myelomonocytic Leukemia, de Novo MDS, MDS Trial in Cleveland (other, drug, genetic)

Completed
Has Results
  • Chronic Myelomonocytic Leukemia
  • +7 more
  • flow cytometry
  • +7 more
  • Cleveland, Ohio
  • +1 more
Feb 21, 2019

MDS, Refractory Anemia With Excess Blasts, Chronic Myelomonocytic Leukemia Trial in Worldwide (rigosertib sodium)

Completed
  • Myelodysplastic Syndromes
  • +3 more
  • rigosertib sodium
  • Stanford, California
  • +34 more
Jun 29, 2020

Relapsed Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia, MDS Trial (biological, drug, procedure)

Withdrawn
  • Relapsed Acute Myeloid Leukemia
  • +2 more
  • Cytokine-induced memory-like NK cells
  • +4 more
  • (no location specified)
Feb 23, 2022

Chronic Lymphocytic Leukemia Trial in Worldwide (Venetoclax)

Completed
Has Results
  • Chronic Lymphocytic Leukemia
  • Louisville, Kentucky
  • +66 more
Nov 9, 2022

Immunodeficiency, Hematopoietic Stem Cell Transplantation Trial run by the National Cancer Institute (NCI) (drug, radiation,

Recruiting
  • Immunodeficiency
  • Hematopoietic Stem Cell Transplantation
  • Post-Transplant Cyclophosphamide (PTCY)
  • +8 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 17, 2022

Cytokine Release Syndrome Trial in United States (Itacitinib, Immune effector cell therapy, Placebo)

Recruiting
  • Cytokine Release Syndrome
  • Miami, Florida
  • +9 more
Oct 25, 2022